Home > Insider Trading > Filing (0001209191-21-051433)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1408500	E Martin Cearnal	2525 West End Ave. Suite 950 Nashville TN 37203	Sr Vp/Chief Commercial Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-06-30	105	$2.93	165,054	No	4	P	Direct
Common Stock	Acquisiton	2021-07-01	105	$2.91	165,159	No	4	P	Direct
Common Stock	Acquisiton	2021-07-02	105	$2.94	165,264	No	4	P	Direct
Common Stock	Acquisiton	2021-07-06	105	$3.14	165,369	No	4	P	Direct
Common Stock	Acquisiton	2021-07-07	105	$3.19	165,474	No	4	P	Direct
Common Stock	Acquisiton	2021-07-08	105	$3.18	165,579	No	4	P	Direct
Common Stock	Acquisiton	2021-07-09	105	$3.13	165,684	No	4	P	Direct
Common Stock	Acquisiton	2021-07-12	105	$3.33	165,789	No	4	P	Direct
Common Stock	Acquisiton	2021-07-13	105	$3.48	165,894	No	4	P	Direct
Common Stock	Acquisiton	2021-07-14	105	$3.33	165,999	No	4	P	Direct
Common Stock	Acquisiton	2021-07-15	105	$3.27	166,104	No	4	P	Direct
Common Stock	Acquisiton	2021-07-16	105	$3.28	166,209	No	4	P	Direct
Common Stock	Acquisiton	2021-07-19	105	$3.23	166,314	No	4	P	Direct
Common Stock	Acquisiton	2021-07-20	105	$3.24	166,419	No	4	P	Direct
Common Stock	Acquisiton	2021-07-21	105	$3.26	166,524	No	4	P	Direct
Common Stock	Acquisiton	2021-07-22	105	$3.36	166,629	No	4	P	Direct
Common Stock	Acquisiton	2021-07-23	105	$3.35	166,734	No	4	P	Direct
Common Stock	Acquisiton	2021-07-26	105	$3.39	166,839	No	4	P	Direct
Common Stock	Acquisiton	2021-07-27	105	$3.39	166,944	No	4	P	Direct
Common Stock	Acquisiton	2021-07-28	105	$3.42	167,049	No	4	P	Direct
Common Stock	Acquisiton	2021-07-29	105	$3.42	167,154	No	4	P	Direct
Common Stock	Acquisiton	2021-07-30	105	$3.31	167,259	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.